Antipsychotic drugs for patients with schizophrenia and predominant or prominent negative symptoms: a systematic review and meta-analysis.

Name: Antipsychotic drugs for patients with schizophrenia and predominant or prominent negative symptoms: a systematic review and meta-analysis.
Creator: Marc Krause
Published: 2018-11-08T09:08:46.532Z
Keywords: Drugs

Krause, Marc; Zhu, Yikang; Huhn, Maximilian; Bighelli, Irene; Nikolakopoulou, Adriani; Leucht, Stefan

doi:10.17632/59m4njvbrf.1

Antipsychotic drugs for patients with schizophrenia and predominant or prominent negative symptoms: a systematic review and meta-analysis.

Published: 8 November 2018| Version 1 | DOI: 10.17632/59m4njvbrf.1

Contributors:

Marc Krause, Yikang Zhu, Maximilian Huhn, Irene Bighelli, Adriani Nikolakopoulou, Stefan Leucht

Description

Data of the following publication: Krause, Marc; Zhu, Yikang; Huhn, Maximilian; Schneider-Thoma, Johannes; Bighelli, Irene; Nikolakopoulou, Adriani; Leucht, Stefan (2018): Antipsychotic drugs for patients with schizophrenia and predominant or prominent negative symptoms: a systematic review and meta-analysis. In: European archives of psychiatry and clinical neuroscience 268 (7), S. 625–639. DOI: 10.1007/s00406-018-0869-3.

Antipsychotic drugs for patients with schizophrenia and predominant or prominent negative symptoms: a systematic review and meta-analysis.

Description

Files

Categories

Licence